BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26337342)

  • 1. Pharmacological manipulation of AID.
    Methot SP; Di Noia JM
    Oncotarget; 2015 Sep; 6(29):26550-1. PubMed ID: 26337342
    [No Abstract]   [Full Text] [Related]  

  • 2. Consecutive interactions with HSP90 and eEF1A underlie a functional maturation and storage pathway of AID in the cytoplasm.
    Methot SP; Litzler LC; Trajtenberg F; Zahn A; Robert F; Pelletier J; Buschiazzo A; Magor BG; Di Noia JM
    J Exp Med; 2015 Apr; 212(4):581-96. PubMed ID: 25824822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanisms regulating the subcellular localization of AID.
    Patenaude AM; Di Noia JM
    Nucleus; 2010; 1(4):325-31. PubMed ID: 21327080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90.
    Orthwein A; Patenaude AM; Affar el B; Lamarre A; Young JC; Di Noia JM
    J Exp Med; 2010 Nov; 207(12):2751-65. PubMed ID: 21041454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic activation-induced cytidine deaminase (AID) exists in stoichiometric complex with translation elongation factor 1α (eEF1A).
    Häsler J; Rada C; Neuberger MS
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18366-71. PubMed ID: 22042842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytoplasmic AID complex.
    Häsler J; Rada C; Neuberger MS
    Semin Immunol; 2012 Aug; 24(4):273-80. PubMed ID: 22698843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic pocket inaccessibility of activation-induced cytidine deaminase is a safeguard against excessive mutagenic activity.
    King JJ; Manuel CA; Barrett CV; Raber S; Lucas H; Sutter P; Larijani M
    Structure; 2015 Apr; 23(4):615-27. PubMed ID: 25728927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
    Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
    Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase.
    Pratt WB
    Annu Rev Pharmacol Toxicol; 1997; 37():297-326. PubMed ID: 9131255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase.
    McBride KM; Barreto V; Ramiro AR; Stavropoulos P; Nussenzweig MC
    J Exp Med; 2004 May; 199(9):1235-44. PubMed ID: 15117971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced cytidine deaminase (AID) is localized to subnuclear domains enriched in splicing factors.
    Hu Y; Ericsson I; Doseth B; Liabakk NB; Krokan HE; Kavli B
    Exp Cell Res; 2014 Mar; 322(1):178-92. PubMed ID: 24434356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined nuclear and nucleolar localization motif in activation-induced cytidine deaminase (AID) controls immunoglobulin class switching.
    Hu Y; Ericsson I; Torseth K; Methot SP; Sundheim O; Liabakk NB; Slupphaug G; Di Noia JM; Krokan HE; Kavli B
    J Mol Biol; 2013 Jan; 425(2):424-43. PubMed ID: 23183374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AID and partners: for better and (not) for worse.
    Storck S; Aoufouchi S; Weill JC; Reynaud CA
    Curr Opin Immunol; 2011 Jun; 23(3):337-44. PubMed ID: 21439803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.
    Basu U; Chaudhuri J; Alpert C; Dutt S; Ranganath S; Li G; Schrum JP; Manis JP; Alt FW
    Nature; 2005 Nov; 438(7067):508-11. PubMed ID: 16251902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recruitment of activation induced cytidine deaminase to the immunoglobulin locus by a regulatory element.
    Kim Y; Tian M
    Mol Immunol; 2010 May; 47(9):1860-5. PubMed ID: 20334924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
    Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
    Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription-targeted DNA deamination by the AID antibody diversification enzyme.
    Chaudhuri J; Tian M; Khuong C; Chua K; Pinaud E; Alt FW
    Nature; 2003 Apr; 422(6933):726-30. PubMed ID: 12692563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple p53 protein isoforms and formation of oligomeric complexes with heat shock proteins Hsp70 and Hsp90 in the human mammary tumor, T47D, cell line.
    Selkirk JK; Merrick BA; Stackhouse BL; He C
    Appl Theor Electrophor; 1994; 4(1):11-8. PubMed ID: 7811761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of nuclear receptors with hsp90 in living cells.
    Manninen T; Purmonen S; Ylikomi T
    J Steroid Biochem Mol Biol; 2005 Jun; 96(1):13-8. PubMed ID: 15908199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants.
    Durandy A; Peron S; Taubenheim N; Fischer A
    Hum Mutat; 2006 Dec; 27(12):1185-91. PubMed ID: 16964591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.